insights_auto
Why is HROW down 5.21%?
Dive Deeperchevron_right
HROW:NASDAQ
Harrow Inc
$28.93
arrow_downward
-5.21%(-1.59) 1D
Oct 9, 11:33:50 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HROW...
Open
$30.73
High
$30.90
Low
$27.00
Mkt. cap
1.08B
Avg. vol.
550.16K
Volume
820.16K
52-wk high
$54.85
52-wk low
$27.00
EPS
-$1.00
Beta
0.19
Shares outstanding
37.49M
No. of employees
373
Open
$30.73
High
$30.90
Low
$27.00
Mkt. cap
1.08B
Avg. vol.
550.16K
Volume
820.16K
52-wk high
$54.85
52-wk low
$27.00
EPS
-$1.00
Beta
0.19
Shares outstanding
37.49M
No. of employees
373
News stories
From web sources and news partners
Investing.com
·
1 hour ago
Harrow stock hits 52-week low at 28.51 USD
Zacks
·
2 hours ago
Do Options Traders Know Something About Harrow Stock We Don't?
TradingView
·
3 hours ago
Do Options Traders Know Something About Harrow Stock We Don't?
Simply Wall Street
·
5 hours ago
Clinical Data Showcase Could Be A Game Changer For Harrow (HROW)
Profile
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
About Harrow Inc
CEOMark L. Baum Esq.
Employees373
Founded2012
HeadquartersNashville, Tennessee, United States
SectorPharmaceutical industry
Websiteharrow.com